Type 1 diabetes: symptoms, the tests that confirm it, and treatment

What type 1 diabetes is, how it starts years before symptoms, the blood tests that tell it apart from type 2, how it is treated, and the warning signs that need emergency care.

Reviewed by LifeFrom’s medical AIPublished November 20, 2026 · 13 min
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    Glucose tells you whether; antibodies tell you which, and when

    Glucose and A1C confirm diabetes only once it has arrived. Islet autoantibodies (GAD65, IA-2, ZnT8, insulin) and C-peptide answer whether it is type 1, and the antibodies can flag type 1 in stages 1 and 2 while glucose is still normal: about 70% of people with two or more reach clinical diabetes within 10 years 1. An A1C of 9% sits well inside the diabetes range and says nothing about the type, which is how adults with type 1 end up treated as type 2 2.

Type 1 diabetes starts quietly, often years before anyone notices thirst or weight loss, as the immune system works through the insulin-making cells of the pancreas. By the time symptoms appear, most of those cells are gone, and without insulin the body burns fat for fuel and makes acids called ketones that can turn into an emergency within days. Over 2 million Americans live with type 1, about 314,000 of them children and teens, out of roughly 40 million Americans with any kind of diabetes, according to the American Diabetes Association's summary of the CDC's National Diabetes Statistics Report 16. This guide covers the stages, the symptoms, the blood tests that separate type 1 from type 2, treatment, and the numbers to watch for life.

01What type 1 is and how it is found

What type 1 diabetes is

Insulin is the hormone that lets glucose leave the blood and enter muscle, fat and liver cells. In type 1 diabetes, immune cells attack the beta cells, the insulin-making cells clustered in the islets of the pancreas. As beta cells die, insulin falls, and glucose piles up in the blood while the cells that need it go short. The American Diabetes Association (ADA) classifies type 1 by this absolute insulin deficiency; in type 2 diabetes the body still makes insulin but responds to it poorly 1. The full side-by-side is on our type 1 vs type 2 comparison, and the wider family of diabetes types is on diabetes.

Eating sugar does not cause type 1 diabetes, weight does not cause it, and no diet prevents it. People with type 1 come in every body size. Insulin resistance can sit on top of type 1, so an adult with type 1 can carry extra weight, which is one reason adults get misclassified.

How missing insulin turns into ketoacidosis

1
Insulin runs low
Beta cells are destroyed, so too little insulin reaches the blood.
2
Glucose stays in the blood
Cells cannot take glucose in, and the liver keeps releasing more. Above about 180 mg/dL (10 mmol/L) the kidneys spill glucose into the urine, and it pulls water out with it.
3
The body burns fat instead
Short of usable glucose, the body breaks down fat, and the liver turns the fatty acids into ketones, a backup fuel.
4
Ketones turn the blood acidic
Without insulin to slow fat breakdown, ketones build faster than the body clears them and the blood turns acidic. That is diabetic ketoacidosis, defined by ketones of 3.0 mmol/L or more and a blood pH (acidity; normal is about 7.4) below 7.3 or bicarbonate (the blood's acid buffer) below 18 mmol/L 4.
The same chain explains the classic symptoms: thirst and frequent urination come from step 2, weight loss from step 3, nausea and deep breathing from step 4.

Type 1 starts years before symptoms: the three stages

Islet autoantibodies are antibodies the immune system makes against beta-cell proteins, and they show up in the blood long before glucose rises. Counting them alongside blood sugar lets doctors stage type 1 diabetes 1. The ADA puts the risk for someone in stage 1 at about 44% for clinical diabetes within 5 years and about 70% within 10 years, with lifetime risk approaching 100% 1.

StageIslet autoantibodiesBlood sugarSymptomsWhat can be done
Stage 1Two or moreNormalNoneRechecks of glucose or A1C on a schedule the care team sets, so stage 3 is caught before DKA; research trials
Stage 2Two or moreAbnormal but below the diabetes range (for example A1C 5.7% to 6.4%, the prediabetes range)NoneTeplizumab can delay stage 3 in people aged 8 and older 3 13; an endocrinologist decides whether it fits
Stage 3Usually presentIn the diabetes rangeOften thirst, frequent urination, weight lossInsulin for life

Teplizumab (brand name Tzield) is an antibody drug given by IV infusion once a day for 14 days. In the trial behind its approval, relatives of people with type 1 who were in stage 2 reached a clinical diagnosis after a median of 48.4 months on teplizumab and 24.4 months on placebo 3. The FDA approved it in November 2022 for people aged 8 and older in stage 2 13. It buys time, about two years at the median, and does not stop the disease.

How type 1 unfolds: insulin-making capacity over time
% of normal insulin outputSymptoms often appear around hereYr 0Yr 1Yr 2Yr 3Yr 4Yr 5Yr 6Yr 7Yr 8Yr 9Yr 10Yr 11Diagnosis (stage 3)
Illustrative shape, not patient data. Beta-cell loss runs for months to years while glucose stays normal, which is why antibody tests can find type 1 in stages 1 and 2 1. The small rise after diagnosis is the honeymoon phase, when remaining beta cells recover some output once insulin starts; it always ends. The point where symptoms start, and the speed of loss, vary widely; loss is fastest in young children.

Relatives of people with type 1 can get islet autoantibody screening through TrialNet, a research network, and the ADA standards support offering screening to people with a family history 1. If a screening test finds antibodies, ask the care team how often to recheck glucose or A1C, and learn the symptoms and the signs of DKA below so stage 3 is caught early. How antibody results are read in general is covered in autoimmune antibodies explained.

Symptoms of type 1 diabetes

The early signs come from glucose spilling into the urine. People often describe the four Ts: toilet (peeing often, including at night), thirsty, tired and thinner. Add hunger, blurred vision, thrush or genital itching, and new bedwetting in a child who was dry at night. Each of the main ones has its own page: always thirsty, frequent urination, unexplained weight loss and fatigue.

In children the symptoms usually build over days to a few weeks. Babies and toddlers cannot say they are thirsty, so the clues are very wet or frequent diapers, a diaper rash that will not clear (often thrush), irritability, weight loss, and vomiting that looks like a stomach bug; the youngest children are the most likely to be in DKA by the time type 1 is found. In adults the symptoms can creep in over months, and an adult who is thirsty and tired may be told they have type 2. In the US SEARCH for Diabetes in Youth study, about 4 in 10 young people diagnosed with type 1 in 2016 were already in DKA at or near diagnosis 12.

The blood tests that diagnose type 1, step by step

Diagnosing type 1 diabetes means answering two questions in order, and each needs its own tests. A glucose or A1C result answers only the first one: an A1C of 9% sits well inside the diabetes range and says nothing about which type. When someone is unwell, a third, urgent check runs alongside both: is this already DKA?

QuestionTestThe number that answers it
1. Is it diabetes?A1C, fasting glucose, 2-hour glucose on an oral glucose tolerance test (OGTT), random glucoseA1C 6.5% or more; fasting glucose 126 mg/dL (7.0 mmol/L) or more; 2-hour OGTT 200 mg/dL (11.1 mmol/L) or more; random glucose 200 mg/dL or more with symptoms. Unless symptoms and glucose are clear-cut, a doctor confirms with a second abnormal result 1
2. Is it type 1?Islet autoantibodies (GAD65, IA-2, ZnT8, insulin); C-peptideOne or more positive antibodies makes type 1 likely; C-peptide below 200 pmol/L (0.6 ng/mL) fits type 1, above 600 pmol/L (1.8 ng/mL) makes it unlikely 2
Alongside: is it an emergency?Blood ketones (beta-hydroxybutyrate), urine ketones, blood pH, bicarbonate, anion gapDKA: glucose 200 mg/dL or more (or known diabetes), blood ketones 3.0 mmol/L or more (or urine ketones 2+ or more), and pH below 7.3 or bicarbonate below 18 mmol/L 4

Three details change how these results read. A1C reflects about three months of glucose, so when type 1 comes on over a few weeks the A1C can still look modest while glucose is already very high; the ADA advises using glucose criteria in that situation 1. Which first test to trust in general is on A1C vs fasting glucose. Insulin autoantibodies count only before, or within about two weeks of, starting insulin, because injected insulin triggers antibodies of its own 2. A small share of people with type 1 test negative for all four antibodies, and C-peptide helps sort those cases 2.

C-peptide is a fragment cut from insulin as the pancreas makes it, and injected insulin contains none, so it measures the body's own insulin output even in someone who injects insulin. The joint consensus of the American Diabetes Association and the European Association for the Study of Diabetes (ADA/EASD) on type 1 in adults reads a random C-peptide against the cutoffs below and finds it most informative more than three years after diagnosis, once the honeymoon phase is over 2. What a low result means in detail is on the low C-peptide page.

Example random C-peptide in an adult diagnosed four years agopmol/L

150 pmol/LExample: fits type 1 · about 0.45 ng/mL
Fits type 10–200Reads two ways200–600Type 1 unlikely600–1000
A C-peptide of 150 pmol/L more than three years after diagnosis means the pancreas makes very little insulin of its own, which fits type 1, a condition treated with insulin. A doctor reads it together with antibody results and history, and the care team decides treatment.
Cutoffs from the ADA/EASD consensus on type 1 diabetes in adults 2: below 200 pmol/L (0.6 ng/mL) is consistent with type 1, 200 to 600 pmol/L is indeterminate, above 600 pmol/L (1.8 ng/mL) makes type 1 unlikely.
Free, no accountRead your blood testHave a lab report with glucose, A1C or C-peptide on it? Read every line of it, free.Read my results

A home glucose meter or a wellness blood panel cannot diagnose type 1 diabetes. A meter can show that glucose is high, which is a reason to see a doctor that day; the antibody and C-peptide tests, and the urgent ketone and pH checks, belong in a clinic or hospital.

Type 1 that starts in adulthood, and LADA

A large share of type 1 cases start in adults. A UK Biobank study that used genetic risk scores found that 42% of type 1 cases before age 60 were diagnosed between 31 and 60, and many of those adults were first treated as type 2 10. LADA (latent autoimmune diabetes in adults) is the slower adult form: antibodies are present, but the pancreas keeps making some insulin for months or years, so tablets can work for a while.

These clues suggest that a type 2 label may be wrong:

  • Normal or low body weight, or fast weight loss around diagnosis
  • Tablets that stop working within months to a few years
  • Ketones in the blood or urine, or an episode of DKA
  • Another autoimmune condition, such as thyroid disease or celiac disease
  • A parent, sibling or child with type 1 or another autoimmune disease
  • Diagnosis before about age 35

The ADA/EASD route for an adult in doubt is antibody testing first, starting with GAD65, then C-peptide if the antibodies are negative or the picture stays unclear 2. The type matters because a person with type 1 treated with tablets alone can slide into DKA. If you were told you have type 2 and several of these clues fit, ask your clinician: "Could this be type 1 or LADA? Can we check GAD65 antibodies and a C-peptide?"

Who gets type 1 diabetes

Type 1 runs in families, but only partly. The largest share of inherited risk sits in the HLA genes, which shape how the immune system tells the body's own tissue from invaders. Even so, most people diagnosed with type 1 have no parent or sibling with it. Having a parent with type 1 raises a child's odds, and the ADA's guidance gives these rough figures 15.

Parent with type 1Child's approximate odds
Father1 in 17
Mother, child born before she turned 251 in 25
Mother, child born after she turned 251 in 100

Something in the environment seems to set off the immune attack in people who carry risk genes. Viral infections, particularly enteroviruses, and early-life factors are under study, and none is proven as a cause.

Type 1 often comes with other autoimmune conditions. Autoimmune thyroid disease affects 17 to 30% of people with type 1 and celiac disease about 1.6 to 16%, so the ADA's guidance for children advises a thyroid-stimulating hormone (TSH) test and celiac screening soon after diagnosis 9; adults are checked too, on a schedule the care team sets. Hashimoto's disease and celiac disease have their own guides; rarer ones include Addison's disease and pernicious anemia.

02Living with type 1

Treatment: insulin for life, and the technology around it

Insulin replaces what the beta cells no longer make, and everyone with stage 3 type 1 diabetes needs it. Most regimens copy a working pancreas with two parts: basal (background) insulin that covers the body's needs between meals and overnight, and bolus insulin for meals and to correct highs. The care team sets every dose, and doses change with food, activity, illness, growth and hormones.

Way to deliver insulinHow it worksWhat it asks of the person
Pens (multiple daily injections)Background insulin once or twice a day, plus mealtime insulin each time you eatSeveral injections a day and a dose decision at every meal
Insulin pumpA small device delivers fast-acting insulin through a thin tube or a patch, a little at a time all day, with extra at mealsChanging the infusion set every few days; a blocked or dislodged set can lead to DKA within hours
Automated insulin delivery (hybrid closed loop)A pump linked to a continuous glucose monitor; software raises or lowers insulin every few minutesEntering carbs for meals and keeping both devices working

Meal insulin is matched to carbohydrate. In the US, people count grams of carbohydrate from the nutrition label and use an insulin-to-carb ratio, set by their care team, that says how many grams one unit of insulin covers. As an illustration of the arithmetic only, a ratio of 1 unit per 10 grams applied to a meal with 60 grams of carbohydrate works out to 6 units; each person's actual ratio, and any correction for a high reading, is set by their care team. A continuous glucose monitor (CGM) is a small sensor worn on the skin that reads glucose every few minutes and alarms on highs and lows. The ADA/EASD consensus supports offering CGM and automated insulin delivery to adults with type 1 2.

There is no special type 1 diet. Sugar is not banned when it is counted and covered by insulin, and the same healthy eating advised for everyone applies. What changes is that carbohydrate has to be counted so the insulin dose matches it.

Beyond insulin, the options are narrow. Teplizumab delays stage 3 in people in stage 2 3. Lantidra (donislecel), donor islet cells infused into the liver, was approved by the FDA in June 2023 for adults who cannot reach their A1C goal because of repeated severe lows 14, and it requires immune-suppressing drugs for as long as the cells work. Islet cells grown from stem cells are in clinical trials. No supplement, diet or herbal product replaces insulin in type 1, and stopping insulin can lead to DKA within hours to a day or two.

The numbers to aim for, and the checks every year

Targets are set with a care team. The common starting points for adults come from the ADA/EASD consensus 2.

MeasureCommon goal for adultsWhat it tells you
A1CUnder 7% for many adults without frequent lows 2Average glucose over about three months
Time in range (CGM)More than 70% of readings between 70 and 180 mg/dL 2How much of the day glucose stays in range
Time below 70 mg/dLUnder 4%, about 1 hour a day 2How often glucose runs low
Time below 54 mg/dLUnder 1%, about 15 minutes a day 2How often glucose runs dangerously low

Children, older adults and pregnant people often have different goals, and pregnancy goals are tighter; pregnancy testing is covered in blood tests in pregnancy.

CalculatorGMI calculatorTurn your CGM average glucose into a GMI, the CGM's estimate of A1C.Work it out
76%lower risk of developing diabetic eye disease (retinopathy) with intensive insulin therapy in the Diabetes Control and Complications Trial (DCCT), in people with no eye disease at the start [[5]]The same trial cut early kidney damage by 39% and nerve damage by 60% 5

Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM [type 1 diabetes].DCCT Research Group, New England Journal of Medicine, 1993 5

IDDM, insulin-dependent diabetes mellitus, was the old name for type 1; retinopathy, nephropathy and neuropathy mean damage to the eyes, kidneys and nerves. Intensive therapy also roughly tripled severe low blood sugar in the trial 5, which is why goals are set with the care team. That damage builds for years without symptoms, and the checks below find it while treatment can still slow it.

TestHow oftenWhat it watches for
A1CEvery 3 months, or twice a year when stable at goal 6Average glucose; fructosamine can stand in when A1C is unreliable
Urine albumin-to-creatinine ratioYearly, starting 5 years after diagnosis 7Early kidney damage, before kidney filtering falls
eGFR (estimated glomerular filtration rate)Yearly, starting 5 years after diagnosis 7Kidney filtering; see chronic kidney disease
Dilated eye examWithin 5 years of diagnosis, then yearly, or every 1 to 2 years if no retinopathy is found 8Diabetic retinopathy
TSHSoon after diagnosis, then every 1 to 2 years 9Autoimmune thyroid disease; TPO antibodies help confirm it
tTG-IgA (tissue transglutaminase antibody) with total IgAIn children, soon after diagnosis and again at about 2 and 5 years 9; at any age, when symptoms appear or as the care team advisesCeliac disease
Lipid panel, including LDLAt diagnosis and regularly afterHeart and blood vessel risk; see how to read your lipid panel

The urine albumin-to-creatinine ratio appears on a urine report; see urine ACR. Kidney numbers in general are explained in kidney function explained.

Low blood sugar: the everyday risk

Injected insulin keeps lowering glucose whether or not the body needs it, so lows come with treatment. The ADA grades them: level 1 is below 70 mg/dL (3.9 mmol/L), level 2 is below 54 mg/dL (3.0 mmol/L), and level 3 is any low where the person needs someone else's help 6. Signs include shaking, sweating, a fast heartbeat, hunger, irritability and confusion; a level 3 low can bring seizures or passing out. Causes and signs in more depth are on hypoglycemia.

Alcohol and exercise both raise the risk of a low hours later, often overnight, because the liver releases less glucose after drinking and muscles keep pulling glucose in after a workout. The people someone with type 1 lives or works with should know the signs of a low and where the glucagon is kept.

CalculatorGlucose converterMeter or report in mmol/L? Convert it to mg/dL and back.Work it out

Sick days, ketones and exercise

Illness raises stress hormones, which push glucose up and make ketones more likely even when someone is barely eating. Sick-day plans tell people with type 1 not to stop background insulin when ill, because without it ketones build fast, and to check ketones when glucose stays above about 240 to 250 mg/dL (13.3 to 13.9 mmol/L), or whatever level the plan sets, or with any vomiting. The care team's plan sets the exact numbers; the bands below are typical plan bands, not diagnostic cutoffs, and only the top one is the DKA threshold 4.

Blood ketones (mmol/L)What it usually meansWhat to do
Below 0.6NormalKeep following the usual plan
0.6 to 1.4Ketones risingFollow the sick-day plan from the care team and recheck
1.5 to 2.9High risk of DKACall the care team now; if you cannot reach them quickly, or there is vomiting, belly pain, fast or deep breathing, or drowsiness, go to the emergency department
3.0 or moreLikely DKA 4Emergency: call 911 or go to the emergency department

Vomiting with ketones, or vomiting that stops you keeping fluids down, needs urgent care: call the care team right away, and go to the emergency department or call 911 if you cannot reach them, if vomiting continues, or if there is belly pain, deep or fast breathing, or drowsiness. Urine ketone strips show a color rather than a number and lag behind the blood; a urine result of 2+ or more counts toward the DKA criteria 4. What the strip measures is on urine ketones.

Exercise usually lowers glucose during a session and for up to a day after, while hard sprints or competition can push it up briefly through adrenaline. High readings before breakfast have their own cause, explained in the dawn phenomenon. For how glucose, A1C and insulin fit together across every type of diabetes, see blood sugar explained.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S27-S49
  2. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021;44(11):2589-2625
  3. Herold KC, Bundy BN, Long SA, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 2019;381(7):603-613
  4. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care 2024;47(8):1257-1275
  5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986
  6. American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S128-S145
  7. American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S239-S251
  8. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S252-S265
  9. American Diabetes Association Professional Practice Committee. 14. Children and adolescents: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S283-S305
  10. Thomas NJ, Jones SE, Weedon MN, et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol 2018;6(2):122-129
  11. Rawshani A, Sattar N, Franzen S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018;392(10146):477-486
  12. Jensen ET, Stafford JM, Saydah S, et al. Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study. Diabetes Care 2021;44(7):1573-1578
  13. US Food and Drug Administration. TZIELD (teplizumab-mzwv) injection, prescribing information. Initial US approval 2022
  14. US Food and Drug Administration. FDA approves first cellular therapy to treat patients with type 1 diabetes. News release, 28 June 2023
  15. American Diabetes Association. Genetics of diabetes
  16. American Diabetes Association. Statistics about diabetes (from the CDC National Diabetes Statistics Report, 2023 data)

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.